Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objective of the study is to assess short-term efficacy and safety of a single treatment of BTX-A-HAC NG over placebo for the improvement in the appearance of glabellar lines and to assess the long term safety and efficacy of BTX-A-HAC NG after repeated injections. The primary objective will be met by demonstrating the superiority of BTX-A-HAC NG over placebo as measured by the ILA of the appearance of the subject’s glabellar lines at maximum frown on Day 29 of the DB period.
Critère d'inclusion
- moderate-to-severe glabellar lines